conivaptan has been researched along with Stroke in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ansari, S; Bidari, S; Gubernick, D; Hedna, VS; Khan, AA; Qureshi, AI; Satriotomo, I | 1 |
Elliott, JP; Jones, SM; Seo, JW; Snell, LD; Zeynalov, E | 1 |
Elliott, JP; Jones, SM; Zeynalov, E | 1 |
1 review(s) available for conivaptan and Stroke
Article | Year |
---|---|
Treatment of stroke related refractory brain edema using mixed vasopressin antagonism: a case report and review of the literature.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Brain Edema; Humans; Male; Middle Aged; Stroke | 2014 |
2 other study(ies) available for conivaptan and Stroke
Article | Year |
---|---|
Arginine-Vasopressin Receptor Blocker Conivaptan Reduces Brain Edema and Blood-Brain Barrier Disruption after Experimental Stroke in Mice.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood-Brain Barrier; Brain Edema; Disease Models, Animal; Mice; Receptors, Vasopressin; Stroke; Water-Electrolyte Balance | 2015 |
Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Brain Edema; Disease Models, Animal; Infarction, Middle Cerebral Artery; Infusions, Intravenous; Male; Mice; Mice, Inbred C57BL; Random Allocation; Receptors, Vasopressin; Stroke | 2016 |